Search Results 561-570 of 7897 for driving with dementia
Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible predictors for mild cognitive impairment and dementia. A Study to ...
The Translational Neuropathology Lab of Melissa E. Murray, Ph.D., at Mayo Clinic is using neuroimaging to diagnose Alzheimer's disease earlier.
Roger Perlmutter, president of Merck Research Laboratories, says that Merck will continue to study the drug in people with less advanced disease. Mayo Clinic ...
Understand more about this brain disorder that's the most common cause of dementia. Also learn about new tests and medicines on the market.
U.S. Senator Susan Collins, the Chairman of the Senate Aging Committee and Co-Chair of the Congressional Task Force on Alzheimer's Disease, and Senator Claire ...
Gene Nearly Triples Risk of Alzheimer's, Global Team Including Mayo Clinic Finds. JACKSONVILLE, Fla. — A gene so powerful it nearly triples the risk of ...
Mayo Clinic is leading a multicenter program that aims to identify biomarkers and potential therapeutic targets for Alzheimer's disease.
It also fortifies pathways in your brain that neurologists say can lead to a better understanding of cognition and dementia. To help better understand how ...
The purpose of this study is to examine the safety and effectiveness of suvorexant (MK-4305) to improve sleep in individuals who have Alzheimer's disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.